Compare TEVA & PUK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TEVA | PUK |
|---|---|---|
| Founded | 1901 | 1848 |
| Country | Israel | Hong Kong |
| Employees | 32842 | 15338 |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 38.3B |
| IPO Year | N/A | N/A |
| Metric | TEVA | PUK |
|---|---|---|
| Price | $31.27 | $30.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $38.63 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 864.1K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.24 | $8.91 |
| P/E Ratio | $28.19 | ★ $23.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.04 | $20.26 |
| 52 Week High | $37.35 | $34.03 |
| Indicator | TEVA | PUK |
|---|---|---|
| Relative Strength Index (RSI) | 54.69 | 56.01 |
| Support Level | $30.70 | $28.70 |
| Resistance Level | $31.99 | $31.51 |
| Average True Range (ATR) | 0.88 | 0.57 |
| MACD | 0.33 | 0.26 |
| Stochastic Oscillator | 82.96 | 86.42 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Originally established in 1848 as the Prudential Mutual Assurance, Investment, and Loan Association, Prudential has changed a lot since then. Set up to sell life insurance and loans to the middle class, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life around 1985. During its time as owner of Jackson, Prudential focused on building a simple chassis-style product portfolio that allowed customers to choose from a variety of add-ons. The company also became renowned for its focus on building the internal capabilities required to support its strong product offerings, including compelling technology and a large, well-trained wholesale salesforce.